GGHC
INSM icon

Gilder Gagnon Howe & Co’s Insmed INSM Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,865
Closed -$440K – 273
2013
Q4 		$440K Buy
+25,865
New +$396K 0.01% 225

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gilder Gagnon Howe & Co's INSM Position: Q1 2014 in Review

Gilder Gagnon Howe & Co sold out of Insmed (INSM) in Q1 2014, closing a stake of 25,865 shares — an estimated $440K sold.

Gilder Gagnon Howe & Co first reported a position in INSM in Q4 2013 and held it in 1 quarter. The position peaked at $440K in Q4 2013. 111 funds tracked by Wall St. Rank hold INSM as of Q1 2014.

  • Gilder Gagnon Howe & Co reported no remaining Insmed position as of Q1 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 25,865 Insmed shares in Q1 2014, an estimated $440K.
  • Gilder Gagnon Howe & Co first reported a position in Insmed in Q4 2013 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Insmed position peaked at $440K in Q4 2013.
  • 111 funds tracked by Wall St. Rank held Insmed as of Q1 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2014, filed 9 May 2014.